Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis - PubMed (original) (raw)
. 2007 Oct 31;113(1):19-28.
doi: 10.1016/j.imlet.2007.07.004. Epub 2007 Aug 21.
Affiliations
- PMID: 17868906
- DOI: 10.1016/j.imlet.2007.07.004
Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis
Kaimeng Hu et al. Immunol Lett. 2007.
Abstract
This study is aimed to verify whether CCL2 can induce Th2 polarization in vivo and subsequently inhibit tumor metastasis. B16 cells (a murine melanoma cell line) highly expressing CCL2 (CCL2-B16 cells) were obtained by transfection with recombinant plasmid CCL2-pcDNA3. Primary thymocytes were co-cultured with CCL2-B16 cells and STAT-6-mediated Th2 polarization was noticed after co-culture. Caudal vein injection of CCL2-B16 cells effectively inhibited pulmonary metastasis in C57BL/6 mice, but not in nude mice, indicating that T cells play a role in CCL2-induced inhibition of tumor metastasis. We found that high level of CCL2 up-regulated the expression of Th2-related cytokine (IL-4) in tumor microenvironment and increased CD4+, CD8+, and CD45RB+ cells in the peripheral blood and tumor tissues. We also demonstrated that inoculation of mice with CCL2-B16 cells prolonged mice survival time when they were reinjected with wildtype B16 cells, implying that CCL2 can activate immuno-memory in mice. It is concluded that high expression of CCL2 can induce Th2 polarization in tumor microenvironment and can effectively inhibit tumor metastasis, which casts new lights on the role of chemokines in reconstruction of immune surveillance in patients suffering from tumors.
Similar articles
- A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
Kobayashi M, Kobayashi H, Pollard RB, Suzuki F. Kobayashi M, et al. J Immunol. 1998 Jun 15;160(12):5869-73. J Immunol. 1998. PMID: 9637498 - Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma.
Oka H, Emori Y, Hayashi Y, Nomoto K. Oka H, et al. Cell Immunol. 2000 Nov 25;206(1):7-15. doi: 10.1006/cimm.2000.1715. Cell Immunol. 2000. PMID: 11161433 - Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma.
Kobayashi M, Fujita K, Katakura T, Utsunomiya T, Pollard RB, Suzuki F. Kobayashi M, et al. Anticancer Res. 2002 Nov-Dec;22(6C):4053-8. Anticancer Res. 2002. PMID: 12553032 - Cytokine phenotypes serve as a paradigms for experimental immune-mediated lung diseases and remodeling.
Kunkel SL, Chensue SW, Lukacs N, Hogaboam C. Kunkel SL, et al. Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S63-6. Am J Respir Cell Mol Biol. 2003. PMID: 14503557 Review. No abstract available. - Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes.
Nishikawa M, Hyoudou K, Kobayashi Y, Umeyama Y, Takakura Y, Hashida M. Nishikawa M, et al. J Control Release. 2005 Dec 5;109(1-3):101-7. doi: 10.1016/j.jconrel.2005.09.017. Epub 2005 Oct 26. J Control Release. 2005. PMID: 16256238 Review.
Cited by
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Lim SY, et al. Oncotarget. 2016 May 10;7(19):28697-710. doi: 10.18632/oncotarget.7376. Oncotarget. 2016. PMID: 26885690 Free PMC article. Review. - Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model.
Takahashi M, Miyazaki H, Furihata M, Sakai H, Konakahara T, Watanabe M, Okada T. Takahashi M, et al. Clin Exp Metastasis. 2009;26(7):817-28. doi: 10.1007/s10585-009-9281-8. Epub 2009 Jul 24. Clin Exp Metastasis. 2009. PMID: 19629725 - CCL2 blockade augments cancer immunotherapy.
Fridlender ZG, Buchlis G, Kapoor V, Cheng G, Sun J, Singhal S, Crisanti MC, Wang LC, Heitjan D, Snyder LA, Albelda SM. Fridlender ZG, et al. Cancer Res. 2010 Jan 1;70(1):109-18. doi: 10.1158/0008-5472.CAN-09-2326. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028856 Free PMC article. - The good and the bad of chemokines/chemokine receptors in melanoma.
Richmond A, Yang J, Su Y. Richmond A, et al. Pigment Cell Melanoma Res. 2009 Apr;22(2):175-86. doi: 10.1111/j.1755-148X.2009.00554.x. Epub 2009 Feb 14. Pigment Cell Melanoma Res. 2009. PMID: 19222802 Free PMC article. Review. - Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment.
Yao Y, Zhang T, Qi L, Liu R, Liu G, Li J, Sun C. Yao Y, et al. Pharmgenomics Pers Med. 2021 Jan 8;14:15-26. doi: 10.2147/PGPM.S283414. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 33447073 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials